{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Columbus",
      "address_1": "1809 Wilson Rd",
      "reason_for_recall": "SubPotent Drug: The firm discovered out of specification results for assay and the extended investigation revealed the potential for lower weight tablets.",
      "address_2": "",
      "product_quantity": "8,550 cartons and bottles",
      "code_info": "Lot #: a) 259666A, Exp. MAR 2014; b) 259666B, Exp. MAR 2014",
      "center_classification_date": "20131211",
      "distribution_pattern": "Nationwide and Puerto Rico",
      "state": "OH",
      "product_description": "Oxcarbazepine Tablets, 150 mg, packaged in a) 10 x 10 count Unit-Dose Tablets in blisters packaged in a carton (NDC 0054-0097-20) and b) 100-count bottle (NDC 0054-0097-25), Rx only, Roxane Laboratories, Inc., Columbus, Ohio 43216",
      "report_date": "20131218",
      "classification": "Class III",
      "openfda": {},
      "recalling_firm": "Boehringer Ingelheim Roxane Inc",
      "recall_number": "D-343-2014",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "66288",
      "termination_date": "20140212",
      "more_code_info": "",
      "recall_initiation_date": "20130318",
      "postal_code": "43228-9579",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}